Publications by authors named "Sara Petta"

Claim this Profile
A
A new nonpeptidic inhibitor of 14-3-3 induces apoptotic cell death in chronic myeloid leukemia sensitive or resistant to imatinib.
Manuela Mancini, Valentina Corradi, Sara Petta, Enza Barbieri, Fabrizio Manetti

J Pharmacol Exp Ther· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein-protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis.
Valentina Corradi, Manuela Mancini, Fabrizio Manetti, Sara Petta, Maria Alessandra Santucci

Bioorg Med Chem Lett· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells.
Manuela Mancini, Sara Petta, Ilaria Iacobucci, Valentina Salvestrini, Enza Barbieri

Cell Signal· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR inhibitor RAD001 (Everolimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-ABL protein.
Manuela Mancini, Valentina Corradi, Sara Petta, Giovanni Martinelli, Enza Barbieri

Leuk Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAD 001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia.
Manuela Mancini, Sara Petta, Giovanni Martinelli, Enza Barbieri, Maria A Santucci

J Cell Biochem· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis